Technical analysis alone can help you with entry and exit points on a stock. It's not completely useless, however, we are dealing with a very volatile biotech stock. So there are a lot of other variables you need to take into account. Down the road, with their pipeline, no doubt it will get the appropriate PPS. Until then everything is just speculation. Buy on the dips, sell on the peaks. We all know every little bit of news that is released is a signal to sell and take profits. We've seen it with the news for FDA approval and the updates on GVAX. That is the reason why the stock won't go up short-term because every little gain we get people sell their shares. As for Buda's chart analysis he continues to post on this board explaining where he predicts the stock will go, but never mentions his entry or exit points? Without that I think it's rather pointless IMO. I still read his posts and value his opinion, but without a set entry or exit point the charts are rather useless.